Bausch Health Companies (BHC) Change in Cash (2009 - 2026)
Bausch Health Companies (BHC) reported Change in Cash of -$13.0 million for Q1 2026, up 70.45% on a YoY basis from -$7.6 million in Q1 2025, and up 13.33% sequentially from -$15.0 million in Q4 2025.
Bausch Health Companies (BHC) Change in Cash (2009 - 2026) Analysis & Trends
Bausch Health Companies (BHC) has 18 years of Change in Cash data on file, last reported at -$13.0 million in Q1 2026.
- For the quarter ending Q1 2026, Change in Cash rose 70.45% year-over-year to -$13.0 million; the trailing twelve-month figure through Mar 2026 stood at $155.0 million (down 61.44% YoY), and the FY2025 full-year result was $124.0 million, down 48.12% from the prior year.
- Change in Cash advanced to -$13.0 million in Q1 2026, from -$15.0 million in the prior quarter.
- In the past five years, Change in Cash ranged from a high of $586.0 million in Q2 2025 to a low of -$1.4 billion in Q3 2022.
- A 5-year average of -$47.5 million and a median of -$13.0 million in 2026 frame the typical range for Change in Cash.
- Across the five-year window, Change in Cash sank 9771.43% in 2022 and soared 543.94% in 2025, its largest moves.
- Tracing BHC's Change in Cash over 5 years: stood at $94.0 million in 2022, then jumped by 93.62% to $182.0 million in 2023, then jumped by 147.8% to $451.0 million in 2024, then plunged by 103.33% to -$15.0 million in 2025, then climbed by 13.33% to -$13.0 million in 2026.
- Business Quant data shows BHC's Change in Cash at -$13.0 million in Q1 2026, -$15.0 million in Q4 2025, and -$403.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 185.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | -509.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -388.85 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -277.40 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 457.70 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | -446.50 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -117.00 Mn |
| 10 | Bausch Health Companies | 1.66 Bn | 1.33 Bn | 2.52 Bn | -13.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -13.00 Mn |
| Dec 31, 2025 | -15.00 Mn |
| Sep 30, 2025 | -403.00 Mn |
| Jun 30, 2025 | 586.00 Mn |
| Mar 31, 2025 | -44.00 Mn |
| Dec 31, 2024 | 451.00 Mn |
| Sep 30, 2024 | 127.00 Mn |
| Jun 30, 2024 | -132.00 Mn |
| Mar 31, 2024 | -207.00 Mn |
| Dec 31, 2023 | 182.00 Mn |
| Sep 30, 2023 | 192.00 Mn |
| Jun 30, 2023 | 57.00 Mn |
| Mar 31, 2023 | -60.00 Mn |
| Dec 31, 2022 | 94.00 Mn |
| Sep 30, 2022 | -1.38 Bn |
| Jun 30, 2022 | -581.00 Mn |
| Mar 31, 2022 | 341.00 Mn |
| Dec 31, 2021 | 215.00 Mn |
| Sep 30, 2021 | -14.00 Mn |
| Jun 30, 2021 | -29.00 Mn |